Target intelligence / Profile preview

RNA, U5E small nuclear 3, pseudogene (RNU5E-3P)

Target
RNU5E-3P
Molecular classification
Other (pseudogene of small nuclear RNA)
01

Overview

RNA, U5E small nuclear 3, pseudogene (RNU5E-3P) refers to a **pseudogene** related to the U5 small nuclear RNA (snRNA) gene family. U5 snRNAs are components of the U5 small nuclear ribonucleoprotein (snRNP), a core part of the **spliceosome** complex, which is essential for pre-mRNA splicing in eukaryotic cells. However, pseudogenes such as RNU5E-3P are annotated as non-functional sequences; they are considered unexpressed genomic remnants with no documented biological activity or role in disease. The vast majority of snRNA-pseudogenes are not thought to generate any functional product, and their clinical or therapeutic significance remains unconfirmed[3][4]. RNU5E-3P should not be considered a therapeutic target, as it lacks protein-coding ability and direct functional relevance. **Notes:** - RNU5E-3P is not an active receptor, enzyme, transporter, or other typical drug target. - It is a member of the pseudogene class, which by definition typically lacks function and is not targeted by drugs. - Information for U5 functional family members (such as RNU5B-1, RNU5A-1) does not extend to pseudogenes[3][4]. - There is no evidence that RNU5E-3P is involved in disease or serves as a biomarker or therapeutic target. - This entry is primarily relevant for genomic annotation and is often excluded from structured drug target databases. **Summary:** RNU5E-3P (RNA, U5E small nuclear 3, pseudogene) is a nonfunctional pseudogene and is not considered a therapeutic target[3][4].

Other names
RNU5E-3P

Beyond the preview

Go deeper on RNA, U5E small nuclear 3, pseudogene (RNU5E-3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U5E small nuclear 3, pseudogene (RNU5E-3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call